Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • BFSI
      • Capital Goods
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Auto
    • Real Estate
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Business»Akums Drugs & Pharmaceuticals bags Prestigious Business Excellence Award 2021
    Business

    Akums Drugs & Pharmaceuticals bags Prestigious Business Excellence Award 2021

    By December 17, 2021No Comments4 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi (India), December 17: Akums Drugs and Pharmaceuticals Ltd., one of India’s largest Contract Drug Research and Manufacturing Organizations (CRAMS), has won the prestigious Business Excellence Award 2021 from CIMS Medica during India Pharma Expo as a Leader in pharma manufacturing and innovation.

    The 10th edition of the annual award recognizes Akums Drugs’ contribution to the healthcare sector. It also acknowledges Akums Drugs & Pharmaceuticals Ltd for excellence in pharma manufacturing and innovation.

    The company offers exclusive services in the field of commercial drug development from the point of formulation till its market launch. The organization has 13 advanced manufacturing units, which collectively are producing 12 per cent of the nation’s drug supply.

    The organization offers a comprehensive range of services starting from formulation development to market launch all en suite.

    Commenting on the award win, Mr. DC Jain said, “Platform like these recognises people and motivates them to do better while continuing to inspire others. We feel humbled and further motivated to serve our nation and take its name across the world..”

    “In a span of 17 years, Akums has become a highly reputed contract manufacturing pharma company of India for its high-quality products and unique business acumen. Currently, Akums is manufacturing more than 12 per cent of India’s total medicinal requirement. Products manufactured by Akums are being preferred by the medical fraternity because of their trust in the efficacy, safety, and quality of formulations. We want to leapfrog and further establish our leadership position as India’s largest & most trusted Pharma CRAMS Company, while also contributing towards AtmaNirbhar Bharat and creating employment opportunities”, Said Arushi Jain – Executive Director – Corporate Growth.

    Indian Pharma Expo: The best trade show for pharmaceutical and healthcare industries

    Indian Pharma Expo (IPE) provides an opportunity for the participating companies to display their products & services to the gamut of visitors globally from the pharma and healthcare industries.

    With Indian Pharma Expo, the benefits are bound to get augmented with the presence of eminent personalities from various sectors of pharma, non-pharma, and healthcare industries. It will gather representation from various companies like pharma manufacturers & marketers, packaging solution providers, machinery solution providers, franchise companies, and many more under one roof.

    IPE is one stop juncture to all those who are planning to expand their business through various channels of franchise and distribution; as well as wholesalers and hospital purchase personnel who seek to buy bulk products at concessional rates.

    Incorporated in 2004 by brothers Sanjeev and Sandeep Jain, Akums Drugs is one of the largest contract producers catering to domestic and multinational pharmaceutical companies, which together produce about 12% of all drugs consumed in India. The company’s clients include pharma companies such as Cipla, Cadila Pharmaceuticals, Glenmark, Novartis, and Mylan.

    Akums attributes its success to its 15,000+ employees. Akums has plant-wise R&D and F&D departments equipped with best in class technology and manpower. It has appointed well-experienced, qualified, and competent technical personnel in departments like Quality Assurance, Quality Control, Production, Personnel & Administration, Engineering, Warehouse, and more. New products developed and offered by Akums are at par with global companies with 830 DCGI approvals, 535 FSSAI approvals, 4 patent grants, and 74 filed patents.

    The company began with a single manufacturing unit and today owns ten state-of-the-art manufacturing facilities that are equipped to produce all modern dosage forms such as tablets, hard gelatin capsules, soft gelatin capsules, powder in sachets, liquid syrups and suspensions, injections, eye/ear drops, ointments, creams, gels, lotions, ayurvedic and herbal preparations, nutraceutical and cosmetic preparations and many more.

    Accolades for Akums

    Akums has consistently strived towards achieving the highest standards of quality, at par with international benchmarks. Some of the awards presented to Akums for their excellent performance across diverse areas of work and production are:

    * INDIA PHARMA LEADER AWARD by Department of Pharmaceuticals, Government of India, consecutively for 2 years.

    * National Award for Excellence in Product Quality and Outstanding Entrepreneurship by Government of India.

    * Best Emerging Companies Excellence Award and Best Corporate Governance Award by Business Today.

    * India Pharma Award for Excellence in Contract Research – Formulation Development by UBM India consecutively for 3 years.

    * The company’s growth and contribution to the pharmaceutical industry earned it a well-deserved position in the list of India’s Next Fortune 500 companies, with an overall sector ranking of 3.

    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Ahead of MILT Congress 2026, Global Industry Leaders Reveal the Trends Reshaping MICE and Luxury Travel

    July 15, 2026

    MVK Agro’s Rs. 275 Crore Expansion; Company Targets Rs. 650-700 Crore Revenue Run-Rate by FY28 – Angel One

    July 15, 2026

    Rawbare Secures Strategic Investment from Teamology to Fuel Next Growth Phase

    July 15, 2026

    Comments are closed.

    Recent Post
    • Ahead of MILT Congress 2026, Global Industry Leaders Reveal the Trends Reshaping MICE and Luxury Travel
    • Analytics Insight Unveils ‘40 Under 40’ July 2026 Special Edition Celebrating Emerging AI and Technology Leaders
    • The Next-Generation Industrial Leader: How Zahra Deesawala Is Balancing Boardroom Strategy with International Sporting Excellence
    • MVK Agro’s Rs. 275 Crore Expansion; Company Targets Rs. 650-700 Crore Revenue Run-Rate by FY28 – Angel One
    • Ratul Puri on Building Integrated Energy Solutions for India’s Rising Power Demand
    • Rawbare Secures Strategic Investment from Teamology to Fuel Next Growth Phase
    • From Folklore to Futuristic Fantasy: Dr. Rajkumar Kishor Reimagines a Manipuri Legend in Keibukeioiba – When the Forest Wakes
    • From Gujarat to Glory: Ajay’s Cafe Wins Two Awards, Emerges as India’s Fastest-Rising Café Brand

    Type above and press Enter to search. Press Esc to cancel.